Studies related to Apolipoprotein B and Ginkgo biloba

Effect Of Ginkgo Biloba (EGb 761) On Treadmill Walking Time Among Adults With Peripheral Artery Disease: A Randomized Clinical Trial

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 62
Sex Both Genders
Age Range 65+
Body Types Overweight
Notes for this study:
Supplementation of 300mg EGb-761 has shown some benefits towards improving walking distance in persons with peripheral artery disease and claudication, but due to large variability it was not seen as statistically significanct.